EA201991359A1 - Фармацевтические лекарственные формы - Google Patents

Фармацевтические лекарственные формы

Info

Publication number
EA201991359A1
EA201991359A1 EA201991359A EA201991359A EA201991359A1 EA 201991359 A1 EA201991359 A1 EA 201991359A1 EA 201991359 A EA201991359 A EA 201991359A EA 201991359 A EA201991359 A EA 201991359A EA 201991359 A1 EA201991359 A1 EA 201991359A1
Authority
EA
Eurasian Patent Office
Prior art keywords
medicinal forms
pharmaceutical medicinal
dosage forms
pharmaceutical dosage
pharmaceutical
Prior art date
Application number
EA201991359A
Other languages
English (en)
Inventor
Стефаниа Беато
Пегги Квинтон
Original Assignee
Новартис Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Новартис Аг filed Critical Новартис Аг
Publication of EA201991359A1 publication Critical patent/EA201991359A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к фармацевтическим лекарственным формам для перорального введения, включающим лекарственное вещество 4-[(5R)-6,7-дигидро-5H-пирроло[1,2-с]имидазол-5-ил]-3-фторбензонитрил или его любую фармацевтически приемлемую соль, и к способам изготовления указанных твердых фармацевтических лекарственных форм.
EA201991359A 2014-07-07 2015-07-06 Фармацевтические лекарственные формы EA201991359A1 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462021271P 2014-07-07 2014-07-07

Publications (1)

Publication Number Publication Date
EA201991359A1 true EA201991359A1 (ru) 2020-03-13

Family

ID=53610933

Family Applications (2)

Application Number Title Priority Date Filing Date
EA201991359A EA201991359A1 (ru) 2014-07-07 2015-07-06 Фармацевтические лекарственные формы
EA201790140A EA033685B1 (ru) 2014-07-07 2015-07-06 Фармацевтические лекарственные формы

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA201790140A EA033685B1 (ru) 2014-07-07 2015-07-06 Фармацевтические лекарственные формы

Country Status (29)

Country Link
US (2) US10143680B2 (ru)
EP (2) EP3166596B1 (ru)
JP (2) JP6731136B2 (ru)
KR (1) KR102468610B1 (ru)
CN (1) CN106470704B (ru)
AR (1) AR101116A1 (ru)
AU (1) AU2015287336B2 (ru)
BR (1) BR112016030243B1 (ru)
CA (1) CA2954393C (ru)
CL (1) CL2017000026A1 (ru)
CY (1) CY1120749T1 (ru)
DK (1) DK3166596T3 (ru)
EA (2) EA201991359A1 (ru)
EC (1) ECSP17008187A (ru)
ES (1) ES2686704T3 (ru)
HR (1) HRP20181406T1 (ru)
HU (1) HUE039037T2 (ru)
IL (1) IL249374B (ru)
LT (1) LT3166596T (ru)
MX (1) MX2016017315A (ru)
PE (1) PE20170201A1 (ru)
PH (1) PH12016502540A1 (ru)
PL (1) PL3166596T3 (ru)
PT (1) PT3166596T (ru)
SG (1) SG11201610227TA (ru)
SI (1) SI3166596T1 (ru)
TN (1) TN2016000557A1 (ru)
TW (1) TWI707682B (ru)
WO (1) WO2016005880A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11992479B2 (en) 2018-05-03 2024-05-28 Damian Pharma Ag R-fadrozole for use in the treatment of aldostonerism

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070191487A1 (en) 2004-03-17 2007-08-16 Rigassi-Dietrich Petra G Galenic formulations of organic compounds
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
CL2008000727A1 (es) * 2007-03-13 2008-10-17 Takeda Pharmaceutical Granulo compuesto por 2-[[6-[(3r)-3-amino-1-piperidinil]-3,4-dihidro-3-metil-2,4-dioxo-1(2h)-pirimidinil]metil]-4-fluorobenzonitrilo o una de sus sales y un aditivo que no comprende celulosa microcristalina; preparacion solida; comprimido y procedimi
MX2012008212A (es) * 2010-01-14 2012-08-03 Novartis Ag Uso de un agente modificador de hormonas suprarrenales.
AU2011293135A1 (en) * 2010-08-27 2013-04-11 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
AU2012304693B2 (en) * 2011-09-08 2016-03-31 Mereo Biopharma 2 Limited Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases
SI2804863T1 (sl) * 2012-01-17 2016-05-31 Novartis Ag Nove oblike in soli zaviralca sinteze ali aromataze dihidropropirolo(1,2-c)imidazolil aldosterona
WO2013126326A1 (en) 2012-02-21 2013-08-29 Celgene Corporation Solid forms of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione, compositions and methods of use thereof
CA2869442C (en) * 2012-04-12 2020-09-08 Novartis Ag Combination of somatostatin-analogs with 11beta-hydroxylase inhibitors
EP2815749A1 (en) 2013-06-20 2014-12-24 IP Gesellschaft für Management mbH Solid form of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione having specified X-ray diffraction pattern

Also Published As

Publication number Publication date
EP3412278A1 (en) 2018-12-12
EP3166596B1 (en) 2018-06-06
KR102468610B1 (ko) 2022-11-21
HRP20181406T1 (hr) 2018-10-19
AU2015287336B2 (en) 2018-06-14
PL3166596T3 (pl) 2018-11-30
IL249374A0 (en) 2017-02-28
LT3166596T (lt) 2018-09-25
IL249374B (en) 2021-09-30
EP3166596A1 (en) 2017-05-17
BR112016030243A2 (pt) 2017-08-22
JP6731136B2 (ja) 2020-07-29
HUE039037T2 (hu) 2018-12-28
TWI707682B (zh) 2020-10-21
SI3166596T1 (sl) 2018-10-30
KR20170029491A (ko) 2017-03-15
CA2954393C (en) 2022-07-19
JP2019194221A (ja) 2019-11-07
TW201613586A (en) 2016-04-16
US10709691B2 (en) 2020-07-14
CN106470704A (zh) 2017-03-01
US20170202808A1 (en) 2017-07-20
MX2016017315A (es) 2017-04-27
CA2954393A1 (en) 2016-01-14
WO2016005880A1 (en) 2016-01-14
PE20170201A1 (es) 2017-04-08
CY1120749T1 (el) 2019-12-11
PH12016502540A1 (en) 2017-04-10
ES2686704T3 (es) 2018-10-19
TN2016000557A1 (en) 2018-04-04
JP2017520590A (ja) 2017-07-27
PT3166596T (pt) 2018-10-19
EA033685B1 (ru) 2019-11-15
AR101116A1 (es) 2016-11-23
CL2017000026A1 (es) 2017-07-28
US10143680B2 (en) 2018-12-04
AU2015287336A1 (en) 2017-01-12
BR112016030243B1 (pt) 2023-04-11
CN106470704B (zh) 2020-07-31
ECSP17008187A (es) 2018-03-31
DK3166596T3 (en) 2018-09-10
US20190060283A1 (en) 2019-02-28
EA201790140A1 (ru) 2017-05-31
SG11201610227TA (en) 2017-01-27

Similar Documents

Publication Publication Date Title
EA201892395A1 (ru) Лекарственные составы ингибитора lsd1
EA201792592A1 (ru) Фармацевтические препараты, содержащие тенофовир и эмтрицитабин
EA201891099A1 (ru) 7-(тиазол-5-ил)пирролопиримида в качестве агониста рецептора tlr7
SG10201902598VA (en) Peptidomimetic macrocycles and formulations thereof
EA201592250A1 (ru) Пиразолопирролидиновые производные и их применение в лечение заболеваний
EA201792591A1 (ru) Фармацевтические препараты
EA201200937A1 (ru) Твердая лекарственная форма тикагрелора
CR20180253A (es) Composiciones terapéuticas para el tratamiento del virus de unmunodeficiencia humana
EA201992116A1 (ru) Фармацевтические составы флороглюцинола и триметилфлороглюцинола
PH12015500823A1 (en) Modified release formulations for oprozomib
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
EA201501164A1 (ru) Твердая фармацевтическая лекарственная форма
EA201692111A1 (ru) Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний
EA201690974A1 (ru) Гидроморфон и налоксон для лечения боли и индуцированного опиоидами синдрома дисфункции кишечника
EA202090542A1 (ru) Высококонцентрированные лекарственные формы придопидина
EA201691231A1 (ru) Фармацевтические лекарственные формы
EA201892842A1 (ru) Фармацевтические композиции, включающие сафинамид
EA201991359A1 (ru) Фармацевтические лекарственные формы
MD3439637T2 (ro) Procedeu pentru formulări solide de mesalazină
TW201613600A (en) Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically
BR112017022855A2 (pt) combinação de dose fixa inviolável que provê liberação rápida de dois fármacos a partir de partículas e um pó
EA201200799A1 (ru) Гепатопротекторное средство
EA202091127A1 (ru) Фармацевтические композиции, включающие сафинамид
EA201691599A1 (ru) Комбинация таурина и рацеметионина для лечения заболеваний печени
UA97982U (uk) Лікарський засіб седативної дії у вигляді таблеток